99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 115/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
  • 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
  • 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
Find Similar Products

Basic Info.

Model NO.
Tranexamic Acid
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>96%
Density
1.095
Molecular Formula
C8h15no2
Formula Weight
157.21
CAS
1197-18-8
Storage Condition
Seal and Store in a Cool, Dry Place
Transport Package
Aluminium Foil Bag and Carton
Specification
Tranexamic Acid
Trademark
HNB
Origin
China
HS Code
2933399021
Production Capacity
25 Mt/Month

Product Description

99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
 

Name  :     Tranexamic Acid
Shape :     Off-white powder

Use for :   

1. Trauma or surgical bleeding of organs rich in plasminogen activator, such as prostate, urethra, lung, brain, uterus, adrenal gland, thyroid and liver. 2. Used as thrombolytic drugs, such as tissue type plasminogen activator (t-PA), streptokinase and urokinase antagonist.
3, induced abortion, early placental exfoliation, stillbirth and amniotic fluid embolism caused by fibrinolytic bleeding.
4. Menorrhage, anterior chamber hemorrhage and severe nosebleed with increased local fibrinolysis.
5. For mild bleeding caused by central aneurysm rupture, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage, the application of this product is better than other antifibrinolytic drugs, but we must pay attention to the dangerous stairway complicated with cerebral edema or cerebral infarction. For severe patients with surgical indications, this product can only be used as an adjuvant drug.
6. It is used to treat hereditary angioedema, which can reduce the number and severity of attacks.
7, hemophilia patients with active bleeding.
8. It has definite effect on chloasma.

                     

             

                      
99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

 
99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8           99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

 

 

 

 

99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-899% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-899% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-899% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-899% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier